Exploiting the signatures of nanoplasmon-exciton coupling on proton sensitive insulator-semiconductor devices for drug discovery applications
- Submitting institution
-
University of Ulster
- Unit of assessment
- 12 - Engineering
- Output identifier
- 77505421
- Type
- D - Journal article
- DOI
-
10.1039/c8nr04540b
- Title of journal
- Nanoscale
- Article number
- -
- First page
- 13320
- Volume
- 10
- Issue
- 28
- ISSN
- 2040-3364
- Open access status
- Technical exception
- Month of publication
- June
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
1
- Research group(s)
-
A - Healthcare Sensor Systems
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- Plasmonic nanoparticles were combined with FET devices via CMOS process to screen candidate compounds for inhibitors of kinases for chemotherapy. This patented technology, WO2015150822A is currently being supported by Sharp technologies - 2 PhD studentships and support for a start-up biotIP at the University of Bath. biotIP aims to bring the demonstrated proof of concept into high throughput chip format. These array chips will screen 10,000 chemical compounds in a single day, which normally takes 2-3 years with existing screening tools.
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -